Cepheid
Danaher Agrees to Provide Cepheid Tuberculosis Test to Global Fund at Cost
The tuberculosis test cartridges will be offered at $7.97 each to the Global Fund and less-developed countries eligible for Cepheid's Global Access Program.
Cepheid Nabs CE-IVD Mark for Molecular NPM1 Mutation Test for AML Monitoring
The test quantifies mutant NPM1 mRNA transcripts in peripheral blood specimens from patients with acute myeloid leukemia.
People in the News at Invitae, Cepheid, Nucleai, Angle, Quantum-Si, Twist Bioscience
Executive and academic appointments, promotions, and departures in omics and molecular diagnostics for the week of May 22, 2023.
The firm saw total revenues decrease 7 percent, with core revenues down 4 percent and base business core revenue growth of 6 percent.
The firm's planned launches include a respiratory virus panel, a gastrointestinal panel, and a fingerstick tuberculosis test, it revelaed this week at ECCMID.